Analytical Data
-
Gene name
LARP1B
- Application
-
Alternative Names
La ribonucleoprotein domain family member 1BLa ribonucleoprotein domain family member 2La-related protein 2
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q659C4
-
Expression Region
1-201aa
-
Molecular Weight
40.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LARP1B, or La ribonucleoprotein domain family member 1B, is a protein that plays a crucial role in the regulation of gene expression and is implicated in various cellular processes, including mRNA stability, translation, and cellular stress responses. As an isoform of the larger LARP1 family, LARP1B's specific functions are of significant interest in both basic and applied research, especially in the context of cancer biology and developmental processes. Recent studies have indicated that LARP1B may be involved in oncogenic signaling pathways, influencing cell proliferation and survival. Understanding the molecular mechanisms of LARP1B can provide insights into its potential as a therapeutic target in cancer and other diseases characterized by dysregulated mRNA metabolism. Moreover, the development of recombinant LARP1B proteins allows researchers to investigate its structural properties, binding interactions, and functional domains. This not only enhances our understanding of the protein's biology but also facilitates the identification of small molecules or peptides that can modulate its activity. Consequently, research involving LARP1B recombinant proteins is critical for elucidating their role in cellular homeostasis and disease, paving the way for innovative therapeutic strategies.
